This case, identified through NGS, displays a distinct MPNST subtype characterized by CD274/PD-L1 amplification, CDKN2A loss, TP53 mutation, and TET2 mutation. The gene discussed is CDKN2A; the disease is malignant peripheral nerve sheath tumor.